Laboratory Workup for Persistent Monocytosis and Unintentional Weight Loss
The appropriate laboratory workup for a patient presenting with persistent monocytosis and unintentional weight loss should include a complete blood count with differential, comprehensive metabolic panel, serum protein electrophoresis, bone marrow aspiration and biopsy, and appropriate imaging studies to rule out hematologic malignancies, particularly chronic myelomonocytic leukemia (CMML). 1
Initial Laboratory Evaluation
Complete Blood Count (CBC) with differential and peripheral blood smear examination 2, 1
- Look for other cytopenias, abnormal cell morphology, and Rouleaux formation
- Quantify the degree of monocytosis (>1×10⁹/L is significant)
- Assess monocyte morphology on peripheral smear
- Blood urea nitrogen (BUN)
- Serum creatinine and creatinine clearance
- Serum electrolytes
- Liver function tests
- Serum calcium
- Albumin
- Lactate dehydrogenase (LDH)
- Beta-2 microglobulin
Inflammatory Markers 1
- Erythrocyte sedimentation rate (ESR)
- C-reactive protein (CRP)
Protein Studies
Serum Protein Studies 2
- Serum protein electrophoresis (SPEP)
- Serum immunofixation electrophoresis (SIFE)
- Quantitative immunoglobulins
- Serum free light chain assay
Urine Studies 2
- 24-hour urine for total protein
- Urine protein electrophoresis (UPEP)
- Urine immunofixation electrophoresis (UIFE)
Advanced Testing
- Bone marrow aspiration and biopsy
- Assessment of percentage of plasma cells and blast cells
- Cytogenetic analysis
- Flow cytometry for immunophenotyping
- Molecular testing for genetic abnormalities
Flow Cytometry 1
- Assess for aberrancies in monocytic lineage
- Look for abnormal CD11b/HLA-DR, CD36/CD14
- Check for overexpression of CD56
Cytogenetic and Molecular Testing 1
- Conventional karyotyping
- Testing for Philadelphia chromosome or BCR-ABL1 fusion gene
- Next-generation sequencing for mutations in TET2, ASXL1, SRSF2, and other genes associated with myeloid neoplasms
Imaging Studies
Skeletal Survey 2
- X-rays to detect lytic bone lesions if multiple myeloma is suspected
Advanced Imaging 2
- Full-body FDG-PET-CT if lymphoma or multiple myeloma is suspected
- MRI of specific areas if indicated by symptoms
Additional Testing Based on Clinical Suspicion
Infectious Disease Workup 1
- Blood cultures
- Serologic testing for HIV, HCV, EBV, CMV
- Testing for tuberculosis, brucellosis, or parasitic infections if clinically indicated
Autoimmune Workup 1
- Antinuclear antibodies (ANA)
- Rheumatoid factor (RF)
- Other autoimmune markers if inflammatory disease is suspected
Diagnostic Algorithm
Confirm persistent monocytosis (>1×10⁹/L for at least 3 months) 1
Rule out reactive causes:
- Infections
- Inflammatory conditions
- Medications
- Recovery from bone marrow suppression
If reactive causes are ruled out or monocytosis persists despite treatment:
- Proceed with bone marrow evaluation
- Perform cytogenetic and molecular testing
Evaluate for specific hematologic malignancies:
Follow-up Recommendations
- For persistent unexplained monocytosis, repeat CBC every 2-4 weeks initially 1
- If monocytosis persists beyond 3 months without clear etiology, hematology referral is warranted 1
- For patients with weight loss, additional workup for malignancy should be considered, including gastrointestinal evaluation and imaging studies 3
Pitfalls to Avoid
- Don't attribute monocytosis solely to infection without appropriate workup, especially in the setting of weight loss
- Don't delay bone marrow evaluation in patients with persistent monocytosis and concerning features like weight loss
- Don't forget to assess for multiple myeloma in older patients with unexplained weight loss and cytopenias
- Don't miss the opportunity to diagnose CMML early by failing to perform appropriate genetic testing
The combination of persistent monocytosis and unintentional weight loss is concerning for a hematologic malignancy and warrants a thorough evaluation with the tests outlined above.